News | October 18, 2019
Results from nine clinical trials of Foamix Pharmaceutical investigational products will be presented in five posters at the 39th Annual Fall Clinical Dermatology Conferencein Las Vegas. Findings relate FMX101 for the treatment of...
News | June 26, 2019
Results of the phase 3b/4 ANSWER study, recently published onlinein the Journal of the American Academy of Dermatology, show that concomitant use of Oracea Capsules and Soolantra Cream provided significant improvement in...
News | December 19, 2018
The National Rosacea Society (NRS) has new grants available in 2019 to support research into potential causes and other key aspects of rosacea that may lead to improvements in its management, prevention, or potential cure. The deadline...
2018 saw new approvals and clearances for acne, impetigo, psoriasis, and skin cancer from Ortho Dermatologics, Sun Pharma, Cutanea, and more. Plus, updates for Restylane, new devices from BTL, Cutera, and others.
Foamix Submits NDA for FMX103 for the Treatment of Moderate-to-Severe Papulopustular Rosacea
DermWireTV: Skin Cancer Foundation’s Big See, Cosmetic Consumer Insights, Cosmetic Bootcamp Recap
Nestlé Enters into Negotiations to Sell Nestlé Skin Health to Consortium Led by EQT and ADIA
AAD Honors Dr. Robert Brodell for Establishing Free Clinic in the Mississippi Delta